Target intelligence / Profile preview

Digestion-resistant maltodextrin (RMD)

Target
RMD
Molecular classification
Other
01

Overview

Fibersol-2 is a commercially available digestion-resistant maltodextrin (RMD), a type of soluble, non-viscous dietary fiber derived from cornstarch through controlled enzymatic hydrolysis [3, 4]. It is characterized by a unique set of glycosidic linkages that make it resistant to human digestive enzymes, allowing it to pass through the upper gastrointestinal tract and reach the colon intact [10]. In the large intestine, Fibersol-2 functions as a prebiotic, undergoing fermentation by beneficial bacteria to produce short-chain fatty acids (SCFAs), which are vital for maintaining gut health and regulating metabolism [2, 7]. Clinically, it is utilized for its ability to moderate postprandial blood glucose and lipid levels, improve intestinal regularity, and enhance satiety via the stimulation of hormones such as GLP-1 and PYY [3, 5, 6]. Emerging research also highlights its potential anti-tumor activity, specifically its ability to inhibit the growth of colorectal cancer cells by inducing mitochondrial reactive oxygen species and activating p53-dependent apoptotic pathways [1, 11]. Recognized as safe (GRAS) by the FDA, Fibersol-2 is a common ingredient in functional foods, beverages, and dietary supplements intended to improve metabolic and digestive health [4].

Other names
Fibersol-2Indigestible dextrinNondigestible dextrinSoluble corn fiberResistant maltodextrin
02

Mechanism of action

Resistant to human digestive enzymes; fermented by colonic microflora into short-chain fatty acids (SCFAs) such as butyrate; competitively inhibits intestinal glucose absorption; stimulates the secretion of satiety hormones GLP-1 and PYY; induces mitochondrial ROS and Bax-dependent apoptosis in specific cancer cell lines

03

Biological functions

ApoptosisOther
04

Disease associations

CancerCardiovascular diseaseOther
05

Safety considerations

Gastrointestinal discomfortBloatingFlatulenceOsmotic diarrhea at high doses
06

Biomarkers

Postprandial blood glucoseSerum triglyceridesHemoglobin A1cBifidobacterium countsGlucagon-like peptide-1 (GLP-1)Peptide YY (PYY)

Beyond the preview

Go deeper on Digestion-resistant maltodextrin (RMD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Digestion-resistant maltodextrin (RMD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call